Smart Inhalers Market Size To Reach $91.9 Billion By 2033

August 2025 | Report Format: Electronic (PDF)

Smart Inhalers Market Growth & Trends

The global smart inhalers market size is estimated to reach USD 91.9 billion by 2033, registering to grow at a CAGR of 19.6% from 2025 to 2033, according to a new report by Grand View Research, Inc. The growth of the smart inhaler market is driven by several key factors, including the rising prevalence of respiratory diseases, increased awareness initiatives, the integration of digital technologies in medical devices, and the development of advanced products by market players. The global rise in chronic respiratory diseases, exacerbated by pollution and low immunity, particularly asthma and COPD, fuels demand for inhalers. According to the American Lung Association, approximately 11.7 million people in the U.S., or 4.6% of adults, were diagnosed with COPD in 2022, which is expected to boost demand for technologically advanced inhalers.

Smart inhalers offer benefits over traditional ones, such as dosage reminders, health tracking, adherence support, and data-driven insights. Market players are actively investing in innovative solutions to meet evolving demands. For example, Aptar Pharma introduced HeroTracker Sense in April 2022, transforming conventional inhalers into smart devices, and partnered with Lupin Limited in January 2020 to launch the ADHERO device, which tracks medication usage via the “MyAdhero” application. These advancements are anticipated to drive global demand for smart inhalers.

In addition, government and private sector initiatives are enhancing awareness about respiratory diseases. The American Lung Association’s “Addressing COPD” project, launched in November 2022, aims to improve the care of 12.5 million COPD patients in the U.S. Such efforts, combined with the growing availability of advanced devices, significantly contribute to the smart inhaler market’s growth.

key Request a free sample copy or view report summary: Smart Inhalers Market Report

Smart Inhalers Market Report Highlights

Based on type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). The MDI segment held the largest revenue share of 64.2% in 2024 and is anticipated to witness fastest growth from 2025 to 2033. This is attributable to their increasing popularity as they are easy to use in fixed-dose short bursts sprays.
Based on indication, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and others. The COPD segment dominated the market with a largest revenue share in 2024, owing to the high prevalence of COPD globally and increasing awareness about this disease.
Based on distribution channel, the market is segmented into hospital, retail, and online pharmacies. The hospital pharmacies segment held the largest revenue share in 2024. Hospital pharmacies offer better flexibility, comfort, and convenience for purchasing smart inhalers for hospitalized patients.
Based on end use, the market is segmented into hospitals, home care settings, and others. The hospitals accounted for the largest revenue share in 2024. The growth is attributed to the rapid advancements in healthcare infrastructure and expanding public-private partnerships.
In 2024, North America held the largest revenue share of 44.64%, due to its developed healthcare infrastructure and adoption of advanced medical devices.